Stage II Marginal Zone Lymphoma
1 clinical trials · Condition
◉ Watch Stage II Marginal Zone Lymphoma
| Record | Firm | Date |
|---|---|---|
| Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma (NCT00288067) | National Cancer Institute (NCI) | 2005-10-01 |
Track Stage II Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.